BREAKING: Lin et al. (Hanna) study shows transplacental transmission of the COVID vaccine mRNA: Evidence from Placental, Maternal and Cord Blood Analyses Post-Vaccination; Dr. Jim Thorp comments?

I ask Dr. Jim (James) Thorp to comment on this breaking study showing what we knew in terms of the COVID vaccine, the contents e.g. mRNA, spike protein, antibodies etc. crossing placenta, breast milk

This study adds to the existing body of evidence that the content of the COVID vaccine can impact the baby in utero and because the vaccine makers did not study the impact of this in the registrational studies and did not include pregnant women, then we are at a loss. This study thus adds critical information so that pregnant women can make informed decisions and IMO, the decision based on all that we knew now near 2 years, and know, is that the COVID mRNA vaccine (Moderna and Pfizer), based on the Malone, Bourla, Bancel, Weissman, Sahin, Kariko et al. technology and vaccine, MUST be stopped completely, never be given to ANYONE, NO one, no infant, no child, no adult, no elderly. It is toxic, ineffective, dangerous and deadly.

There must be complete stop to the mRNA gene injections. No moratorium, just complete stoppage.

There needs to be no study of this. The mRNA/LNP platform was known to be dangerous and even Moderna’s CEO Bancel said mRNA is dangerous and expecially multiple doses.

‘The Pfizer and Moderna Assessment Reports provided to the European Medicines Agency concluded that in animal models, a fraction of the administered mRNA dose is distributed to distant tissues, mainly the liver, adrenal glands, spleen, and ovaries. Another animal study showed that lipid nanoparticles (LNPs)-mRNA injections, similar in composition to COVID-19 mRNA vaccines, delivered functional mRNA to the placenta and other fetal organs.

Our recently published study demonstrated that the COVID-19 vaccine mRNA administered to lactating mothers can spread systemically from the injection site to breast milk, indicating it could cross the blood-milk barrier. Another study evaluating the effects of maternal COVID-19 vaccination on the hematopoietic stem progenitor cells in the umbilical cord blood suggested that the LNPs/mRNA vaccines might reach the fetus following maternal vaccination. This report presents two unique cases wherein pregnant individuals were vaccinated with the COVID-19 mRNA vaccine shortly before delivery. This study aimed to assess the presence of COVID-19 vaccine mRNA in the placenta and cord blood following maternal vaccination during human pregnancy.’

Results

The vaccine mRNA was detected in the two placentas tested (Table) using quantitative ddPCR and ISH.

The localization of the vaccine mRNA was mainly in the villus stroma (panels Ab and Ad), with a notably high signal in the decidua of patient 1 (panel Aa) compared to that of patient 2 (Panel Ac).

Using WES, the Spike protein expression was detected in the placenta of patient # 2, but not in patient #1, as demonstrated in panel Aa. Furthermore, the vaccine mRNA was detected in the cord and maternal blood of patient #1 using ddPCR (Table). Unfortunately, no umbilical cord or maternal blood samples were available for analysis in patient #2.

Finally, the integrity of the vaccine mRNA varied across different samples. In the placentas, 23% and 42% of the original integrity were retained in patients 1 and 2, respectively (Table 1). The vaccine mRNA Journal Pre-proof in the maternal blood showed a high integrity level of 85%; however, in the cord blood, it decreased to 13% of the original vaccine mRNA's integrity (panels Bc and Bd)’

https://www.ajog.org/article/S0002-9378(24)00063-2/pdf